Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The closing price of Prime Medicine Inc (NASDAQ: PRME) was $2.03 for the day, up 4.10% from the previous closing price of $1.95. In other words, the price has increased by $4.10 from its previous closing price. On the day, 0.88 million shares were traded. PRME stock price reached its highest trading level at $2.05 during the session, while it also had its lowest trading level at $1.95.
Ratios:
Our analysis of PRME’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.58 and its Current Ratio is at 5.58. In the meantime, Its Debt-to-Equity ratio is 0.27 whereas as Long-Term Debt/Eq ratio is at 0.24.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JMP Securities on December 10, 2024, initiated with a Mkt Outperform rating and assigned the stock a target price of $10.
On May 20, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $10.
Citigroup Upgraded its Neutral to Buy on May 16, 2024, while the target price for the stock was maintained at $10.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRME now has a Market Capitalization of 266256832 and an Enterprise Value of 109508640. For the stock, the TTM Price-to-Sale (P/S) ratio is 89.35 while its Price-to-Book (P/B) ratio in mrq is 1.74. Its current Enterprise Value per Revenue stands at 36.711 whereas that against EBITDA is -0.558.
Stock Price History:
The Beta on a monthly basis for PRME is 1.93, which has changed by -0.6951952 over the last 52 weeks, in comparison to a change of 0.10838497 over the same period for the S&P500. Over the past 52 weeks, PRME has reached a high of $8.27, while it has fallen to a 52-week low of $1.65. The 50-Day Moving Average of the stock is -20.15%, while the 200-Day Moving Average is calculated to be -47.58%.
Shares Statistics:
PRME traded an average of 1.13M shares per day over the past three months and 1597520 shares per day over the past ten days. A total of 131.16M shares are outstanding, with a floating share count of 51.92M. Insiders hold about 60.42% of the company’s shares, while institutions hold 31.20% stake in the company. Shares short for PRME as of 1740700800 were 18042942 with a Short Ratio of 16.02, compared to 1738281600 on 17302954. Therefore, it implies a Short% of Shares Outstanding of 18042942 and a Short% of Float of 26.43.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
